ask="15.50"
ask_size="2000"
average_daily_volume="1939900"
bid="9.12"
bid_size="200"
book_value="-0.25"
change="-0.14"
change_from_200_day_moving_average="2.97"
change_from_50_day_moving_average="1.79"
change_from_52_week_high="-0.66"
change_From_52_week_low="6.84"
change_in_percent="-0.95%"
close="14.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-80.80M"
eps_estimate_current_year="-0.97"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.80"
ex_dividend_date="N/A"
float_shares="94778000"
high="15.20"
high_52_weeks="15.20"
last_trade_date="3/17/2017"
last_trade_price="14.54"
last_trade_size="482822"
last_trade_time="4:00pm"
low="14.40"
low_52_weeks="7.70"
market_capitalization="1.86B"
moving_average_200_day="11.57"
moving_average_50_day="12.75"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="14.42"
pe_ratio="N/A"
peg_ratio="-2.13"
percent_change_from_200_day_moving_average="+25.71%"
percent_change_from_50_day_moving_average="+14.01%"
percent_change_from_52_week_high="-4.34%"
percent_change_from_52_week_low="+88.83%"
previous_close="14.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="12.83"
revenue="146.69M"
shares_outstanding="128198000"
short_ratio="18.90"
stock_exchange="NMS"
symbol="HALO"
volume="2919739"
weeks_range_52="7.70 - 15.20"
